Advertisement

Related Videos

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Varsha Gandhi, PhD, on Ibrutinib

Welcome and Introduction to Vi3C

Amit Sanyal, MD: A Clinician’s Perspective

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Advertisement

Advertisement




Mar
04
Today In Oncology
Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes
CD123-Targeting ADC Shows Activity in AML and BPDCN
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence
Research Suggests AI Pathology Models May Take Unreliable Shortcuts to Identify Cancer Biomarkers
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo